Claims
- 1. A method for increasing circulation in a breathing person, the method comprising:
interfacing a valve system to the person's airway, the valve system being configured to decrease or prevent respiratory gas flow to the person's lungs during at least a portion of an inhalation event; permitting the person to inhale and exhale through the valve system, wherein during inhalation the valve system functions to produce a vacuum within the thorax to increase blood flow back to the right heart of the person, thereby increasing cardiac output and blood circulation.
- 2. A method as in claim 1, wherein the valve system is incorporated into a facial mask, and further comprising coupling the facial mask to the person's face.
- 3. A method as in claim 1, wherein the valve system includes a pressure responsive inflow valve, and further comprising setting an actuating pressure of the valve to be in the range from about 0 cm H2O to about −40 cm H2O.
- 4. A method as in claim 1, further comprising varying the actuating pressure of the valve over time.
- 5. A method as in claim 1, wherein the valve system is further configured to prevent or decrease exhaled gases from exiting the person's lungs during at least a portion of an exhalation event to further increase blood circulation.
- 6. A method as in claim 1, wherein the valve system is interfaced for a time period in the range from about 30 seconds to about 24 hours.
- 7. A method as in claim 1, further comprising adding a supply of oxygen through the valve system to supplement oxygen delivery to the person.
- 8. A method as in claim 1, wherein the person is suffering from a disease that is related to impaired venous blood flow.
- 9. A method as in claim 1, wherein the person is suffering from a disease resulting at least in part from poor blood circulation, and wherein the valve system functions to increase blood circulation to treat the disease.
- 10. A method as in claim 9, wherein the disease is selected from a group consisting of venous stasis ulcers, deep vein thrombosis, wound healing, and lymphedema.
- 11. A method as in claim 9, wherein the disease comprises renal failure.
CROSS-REFERENCES TO RELATED APPLICATIONS
[0001] This application is a continuation in part application of U.S. patent application Ser. No. 10/119,203, filed Apr. 8, 2002, which is a continuation in part application of U.S. patent application Ser. No. 09/854,238, filed May 11, 2001, which is a continuation in part application of U.S. patent application Ser. No. 09/546,252, filed Apr. 10, 2000, which is a continuation of U.S. patent application Ser. No. 08/950,702, filed Oct. 15, 1997 (now U.S. Pat. No. 6,062,219), which is a continuation-in-part application of U.S. patent application Ser. No. 08/403,009, filed Mar. 10, 1995 (now U.S. Pat. No. 5,692,498), which is a continuation-in-part application of U.S. patent application Ser. No. 08/149,204, filed Nov. 9, 1993 (now U.S. Pat. No. 5,551,420), the disclosures of which are herein incorporated by reference.
[0002] This application is also related to U.S. application Ser. No. 09/967029, filed Sep. 28, 2001, the complete disclosure of which is herein incorporated by reference.
Continuation in Parts (6)
|
Number |
Date |
Country |
Parent |
10119203 |
Apr 2002 |
US |
Child |
10224263 |
Aug 2002 |
US |
Parent |
09854238 |
May 2001 |
US |
Child |
10119203 |
Apr 2002 |
US |
Parent |
09546252 |
Apr 2000 |
US |
Child |
09854238 |
May 2001 |
US |
Parent |
08950702 |
Oct 1997 |
US |
Child |
09546252 |
Apr 2000 |
US |
Parent |
08403009 |
Mar 1995 |
US |
Child |
08950702 |
Oct 1997 |
US |
Parent |
08149203 |
Nov 1993 |
US |
Child |
08403009 |
Mar 1995 |
US |